title: Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
abstract: Previous studies have shown that donor hypernatremia and possibly recipient hyponatremia negatively impact graft function after orthotopic liver transplant (OLT). The purpose of this retrospective investigation was to determine whether measured differences in serum sodium values between cadaveric donors and OLT recipients (DeltaNa(+)) influence immediate postoperative allograft function and short-term patient outcomes. Two hundred and fifty patients that underwent OLT from January 2001 to December 2005 were included in this study. The DeltaNa(+) for each donor recipient pair was correlated with standard postoperative liver function tests as well as recipient length of intensive care unit stay (LOICUS), length of hospital stay (LOHS) and recipient survival. The relationship between donor hypernatremia (serum sodium >or= 155 mEq/mL), recipient hyponatremia (serum sodium level <or= 130 mEq/mL), and postoperative outcomes were analyzed as well. Adjustments were made for baseline potential confounders, including model for end-stage liver disease (MELD) score, preservation solution used (HTK vs. UW), recipient and donor demographics and cold ischemia time (CIT). DeltaNa(+) as well as donor hypernatremia and recipient hyponatremia were not found to be associated with immediate postoperative allograft function, intraoperative blood product usage, LOICUS, LOHS or short-term patient survival. However, both the preoperative MELD score and HTK preservation solution used were significantly associated with several patient outcomes. A higher MELD score was associated with both increased red blood cell (RBC) (P < 0.001) and fresh frozen plasma (FFP) usage (P = 0.002), elevated postoperative total bilirubin levels (P < 0.001), increased LOHS (P = 0.04), and a higher 30-day post transplant mortality (P = 0.02). The use of HTK preservation solution was associated with higher mean postoperative aspartate aminotransferase levels (P = 0.02) and decreased mean RBC (P < 0.001) and FFP usage (P = 0.009) compared to UW preservation solution use.
authors.affiliation: Department of General Anesthesiology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, OH 44195, USA. cywinsj@ccf.org
authors.forename: Jacek B
authors.initials: JB
authors.lastname: Cywinski
authors.forename: Edward
authors.initials: E
authors.lastname: Mascha
authors.forename: Charles
authors.initials: C
authors.lastname: Miller
authors.forename: Bijan
authors.initials: B
authors.lastname: Eghtesad
authors.forename: Shunichi
authors.initials: S
authors.lastname: Nakagawa
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Vincent
authors.forename: Nick
authors.initials: N
authors.lastname: Pesa
authors.forename: Jie
authors.initials: J
authors.lastname: Na
authors.forename: John J
authors.initials: JJ
authors.lastname: Fung
authors.forename: Brian M
authors.initials: BM
authors.lastname: Parker
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D006955:Hypernatremia / Q000097:blood / Q000209:etiology / Q000401:mortality; D007010:Hyponatremia / Q000097:blood / Q000209:etiology / Q000401:mortality; D017093:Liver Failure / Q000097:blood / Q000601:surgery*; D016031:Liver Transplantation / Q000502:physiology*; D011183:Postoperative Complications; D011184:Postoperative Period; D011379:Prognosis; D012189:Retrospective Studies; D012964:Sodium / Q000097:blood*; D015996:Survival Rate; D014019:Tissue Donors
chemical_list: D015415:Biomarkers; D012964:Sodium